Case definition and phenotype standardization in drug-induced liver injury
Aithal, G P, Watkins, P B, Andrade, R J, Larrey, D, Molokhia, M, Takikawa, H, Hunt, C M, Wilke, R A, Avigan, M, Kaplowitz, N, Bjornsson, E, Daly, A K
Published in Clinical pharmacology and therapeutics (01.06.2011)
Published in Clinical pharmacology and therapeutics (01.06.2011)
Get more information
Journal Article
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences
Pol, S., Haour, G., Fontaine, H., Dorival, C., Petrov‐Sanchez, V., Bourliere, M., Capeau, J., Carrieri, P., Larrey, D., Larsen, C., Marcellin, P., Pawlostky, J.‐M., Nahon, P., Zoulim, F., Cacoub, P., Ledinghen, V., Mathurin, P., Negro, F., Pageaux, G.‐P., Yazdanpanah, Y., Wittkop, L., Zarski, J.‐P., Carrat, F.
Published in Alimentary pharmacology & therapeutics (01.12.2017)
Published in Alimentary pharmacology & therapeutics (01.12.2017)
Get full text
Journal Article
Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
Cegla, J., Larrey, D., D’Erasmo, L., O’Brien, S., Arca, M.
Published in Atherosclerosis plus (01.12.2023)
Published in Atherosclerosis plus (01.12.2023)
Get full text
Journal Article
Identifying residual risk of hepatocellular carcinoma following hepatitis C virus eradication in compensated cirrhosis: decision-tree and random forest models developed in the French multicenter prospective ANRS CO12 CirVir cohort
Audureau, E, Bourcier, V, Layese, R, Cagnot, C, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Roudot-Thoraval, F, Nahon, P
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohort
Cacoub, P, Nahon, P, Layese, R, Bourcier, V, Cagnot, C, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Roudot-Thoraval, F, Audureau, E
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in France
Willmington, C, Ganne-Carrié, N, Roudot-Thoraval, F, Leroy, V, Fontaine, H, Canva-Delcambre, V, Larrey, D, Pol, S, Mathurin, P, Yazdanpanah, Y, Deuffic-Burban, S
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Clinical and Social Psychological Profiles of Patients with Chronic Hepatitis C Treated with IFN-Free Regimens in France
Cossais, S, Schwarzinger, M, Pol, S, Fontaine, H, Larrey, D, Pageaux, G.-P, Canva, V, Mathurin, P, Yazdanpanah, Y, Deuffic- Burban, S
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Concomitant or Consecutive Infection with Coxiella burnetii and Tickborne Diseases
Rolain, J. M., Gouriet, F., Brouqui, P., Larrey, D., Janbon, F., Vene, S., Jarnestrom, V., Raoult, D.
Published in Clinical infectious diseases (01.01.2005)
Published in Clinical infectious diseases (01.01.2005)
Get full text
Journal Article
Viral Suppression is Not a risk Factor for CKD in Viral Cirrhosis (ANRS CO12 CirVir Prospective Cohort)
Bagnis, C.I, Layese, R, Divard, G, Cacoub, P, Bourcier, V, Corvi, L, Petro-Sanchez, V, Marcellin, P, Guyader, D, Pol, S, Larrey, D, De Ledingen, V, Ouzan, D, Zoulim, F, Deray, G, Roudot-Thoraval, F, Nahon, P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
Corpechot, C, Chazouillères, O, Rousseau, A, Guyader, D, Habersetzer, F, Mathurin, P, Goria, O, Potier, P, Minello, A, Silvain, C, Abergel, A, Debette-Gratien, M, Larrey, D, Roux, O, Bronowicki, J.-P, Boursier, J, de Ledhingen, V, Heurgue-Berlot, A, Nguyen-Khac, E, Zoulim, F, Ollivier-Hourmand, I, Zarski, J.-P, Nkontchou, G, Gaouar, F, Simon, T, Poupon, R
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P0745 : EQ-5D utility index in French patients with chronic hepatits C (CHC) infection: severe comorbidities and perceived progression of CHC infection matter more than actual liver disease stage
Schwarzinger, M, Cossais, S, Deuffic-Burban, S, Pol, S, Fontaine, H, Larrey, D, Pageaux, G.-P, Canva, V, Mathurin, P, Yazdanpanah, Y
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0808 : Improvement in liver function and non-invasive estimates of liver fibrosis 48 weeks after treatment with ombitasvir/paritaprevir/R, dasabuvir and ribavirin in HCV genotype 1 patients with cirrhosis
Wedemeyer, H, Berg, T, Flamm, S.L, Foster, G.R, Craxi, A, Larrey, D, Morgan, T.R, Fried, M.W, Poordad, F, Trinh, R, Lovell, S, Tang, Y, Pedrosa, M, Lopez-Talavera, J.-C, Jacobson, I.M
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0121 : Angiotensin II inhibition to treat severe liver fibrosis: A double-blind randomized trial (ANRS HC19)
Cales, P, Bacq, Y, Bonny, C, Payen, J.L, Guyader, D, Tran, A, Larrey, D, Silvain, C, Rousselet, M.C, Simony, M, Oberti, F, Carrat, F
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
The Benefits of Virosuppression on Progression of Portal Hypertension in Patients with Compensated Viral Cirrhosis (ANRS CO12 CirVir Cohort)
Bureau, C, Thabut, D, Layese, R, Bourcier, V, Corvy, L, Petrov-Sanchez, V, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Zoulim, F, Roulot, D, De Ledinghen, V, Ouzan, D, Tran, A, Bronowicki, J.-P, Riachi, G, Cales, P, Peron, J.-M, Alric, L, Bourliere, M, Mathurin, P, Zarski, J.-P, Roudot-Thoraval, F, Nahon, P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Extrahepatic Cancer is the Second Cause of Non Liver-Related Death in Patients with Compensated Viral Cirrhosis and is Associated with Viral Replication (ANRS CO12 CirVir Prospective Cohort)
Allaire, M, Bourcier, V, Layese, R, Corvi, L, Petrov-Sanchez, V, Marcellin, P, Guyader, D, Larrey, D, De Lédinghen, V, Ouzan, D, Zoulim, F, Roulot, D, Tran, A, Bronowicki, J.-P, Zarski, J.-P, Riachi, G, Calès, P, Péron, J.-M, Alric, L, Bourlière, M, Mathurin, P, Nahon, P, Roudot-Thoraval, F
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
New Recommendations of Baveno Vi Conference for the Screening of Portal Hypertension: An Independent Sequential Validation in Patients with Compensated Viral Cirrhosis Taking into Account Virological Status (Anrs Co12 Cirvir Cohort)
Thabut, D, Bureau, C, Layese, R, Bourcier, V, Corvy, L, Petrov-Sanchez, V, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Zoulim, F, Roulot, D, De Ledinghen, V, Ouzan, D, Tran, A, Bronowicki, J.-P, Riachi, G, Cales, P, Peron, J.-M, Alric, L, Bourliere, M, Mathurin, P, Zarski, J.-P, Roudot-Thorava, P, Nahon, P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Prospective Evidence That Hepatocellular Carcinoma Surveillance in Patients with Compensated Viral Cirrhosis Increases the Probability of Curative Treatment and Survival Taking into Account Lead-Time Bias (Anrs Co12 Cirvir Cohort)
Costentin, C, Layese, R, Bourcier, V, Corvi, L, Petro-Sanchez, V, Marcellin, P, Guyader, D, Pol, S, Larrey, D, de Ledinghen, V, Ouzan, D, Zoulim, F, zarski, J.P, Roulot, D, Tran, A, Bronowicki, J.-P, Riachi, G, Cales, P, Péron, J.M, Alric, L, Bourlière, M, Mathurin, P, Sutton, A, Letouze, E, Zucman-Rossi, J, Roudot-Thoraval, F, Nahon, P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Sustained Virologic Response to Daclatasvir and Sofosbuvir, with or without Ribavirin, among Patients in the French Daclatasvir ATU Programme Infected with HCV Genotypes 4, 5 and 6
Hézode, C, Abergel, A, Chas, J, Conti, F, Cotte, L, Tateo, M, Alric, L, Vergniol, J, Tomei, C, Bernard, P.-H, Loustaud-Ratti, V, Arpurt, J.-P, Blaison, D, Larrey, D, Fedchuk, L, Bennai, Y, Filipovics, A, Fontaine, H, Pageaux, G.-P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
P0328 : Incidence, characteristics and determinants of primary liver cancer occurring during surveillance of compensated HCV cirrhosis according to sustained virological response (ANRS CO12 CirVir)
Nahon, P, Bourcier, V, Layese, R, Talmat, N, Allam, S, Marcellin, P, Guyader, D, Pol, S, Larrey, D, Zoulim, F, Roulot, D, de Lédinghen, V, Ouzan, D, Zarski, J.-P, Trinchet, J.-C, Roudot-Thoraval, F
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
Drug-induced acute liver failure
Larrey, Dominique, Pageaux, Georges-Philippe
Published in European journal of gastroenterology & hepatology (01.02.2005)
Published in European journal of gastroenterology & hepatology (01.02.2005)
Get more information
Journal Article